German device company Transcatheter Technologies is branching out into EVAR with its rhythmically named Tumbao system
Cardio
IDE Approval for Pivotal Investigation of the Angel® Catheter
BiO2 Medical has gained the U.S. FDA’s approval for an IDE clinical investigation to pave the way to market for its Embolism-Preventing Central Venous Catheter.
St.Jude on the Money in Q4
Preliminary revenue results for St. Jude’s fourth quarter see it expecting to report overall net sales growth with starring performances from Atrial Fibrillation
Heart Failure Scaffold Matrix Trial Fully Enrolled
Bellerophon Therapeutics has completed enrollment of its clinical trial of Bioabsorbable Cardiac Matrix for the prevention of congestive heart failure following acute myocardial infarction
Promising Six Month Results from InspireMD’s CGuard™ CARENET Trial
InspireMD will see six month follow-up data from its CGuard™ CARENET trial presented at the forthcoming LINC course later this month.
Transcatheter Technologies to Introduce Mitral Valve System
Best known for its repositionable Trinity TAVI system, Germany’s Transcatheter Technologies GmbH is expanding its product family to include a transcatheter mitral valve implantation (TMVI) version, tagged Tresillo.
New Study Will Evaluate Adjunctive Ablation in ICD/CRT-D Ventricular Tachycardia Treatment
St. Jude’s FlexAbility ablation catheter will be used to assess benefits of catheter ablation as an adjunctive therapy for patients at risk for life-threatening arrhythmias.
ZOLL to Acquire Advanced Circulatory Systems, Inc.
Device company ZOLL® Medical Corporation is to acquire Advanced Circulatory Systems, Inc., which develops technologies to non-invasively increase circulation.
Abbott Completes Topera Acquisition
Abbott has completed its acquisition of Topera, Inc., a company focused on technologies for the diagnosis and treatment of atrial fibrillation.
FDA Clearance and First U.S. Implant of Sorin’s Memo 3D ReChord Annuloplasty Ring
Sorin has gained U.S. FDA clearance for Memo 3D ReChord™, an innovative semi-rigid annuloplasty ring for mitral valve repair.
Philips Targets Domination of Image-Guided Therapy Market with Volcano Acquisition
Royal Philips and Volcano Corporation are set to merge in a deal worth approximately $1 Billion.
Study Points to Short DAPT with COBRA PzF™ Coronary Stent
CeloNova BioSciences, Inc., is celebrating solid results from a First-in-Man clinical trial of its COBRA PzF™ coronary stent system.
Transcatheter Technologies Adds Transfemoral Approach to Trinity TAVI System
The German TAVI peddlers reckon Trinity’s a world beating “third generation” device. And now it can be delivered transfemorally.
Medtronic Touts FDA Approval and Launch of Two New CRT Quadripolar Leads
Newly FDA approved, additional Attain Performa® Quadripolar Leads deliver more options so physicians can optimize delivery of Cardiac Resynchronization Therapy
CE Mark for World’s Only MultiPoint Pacing Pacemaker
Quadra Allure MP™ CRT-P expands the St. Jude Medical heart failure portfolio and is supported by newly presented data that demonstrate an increase in patient response to multipoint pacing therapy
Edwards Lifesciences Chips in to CardioKinetix $50 Million Financing
Edwards Lifesciences has edged its way closer to owning the Parachure Ventricular Partitioning Device, with its investment in Cardiokinetix having the right to buy string attached.